Fernando Rogério Pavan (Fernando R Pavan, Fernando Rogerio Pavan)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Molecules (Basel, Switzerland)

Expert opinion on drug discovery

ChemPlusChem

Pharmaceutics

Universidade Estadual Paulista Júlio de Mesquita Filho Câmpus de Araraquara Faculdade de Ciências Farmacêuticas

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade Estadual Paulista Júlio de Mesquita Filho Câmpus de Araraquara Faculdade de Ciências Farmacêuticas Oct 12 2012

Brazil

Professor :: Ciências Biológicas

Publications

Lúcia B Cavalca, Úlfur Á Atlason, Alexandru Trofin, Camila M Ribeiro, Fernando Rogério Pavan, Peter Joseph Deuss, Dirk-Jan Scheffers
Selectivity and Activity of Benzene-1,2,4-triol and its Dimers as Antimicrobial Compounds Against Xanthomonas citri subsp. citri. ChemPlusChem 89 (6) (2024)
Christian S Carnero Canales, Aline Renata Pavan, Jean Leandro Dos Santos, Fernando Rogério Pavan
In silico drug design strategies for discovering novel tuberculosis therapeutics. Expert opinion on drug discovery (2024)
Lúcia B Cavalca, Úlfur Á Atlason, Alexandru Trofin, Camila M Ribeiro, Fernando Rogério Pavan, Peter Joseph Deuss, Dirk-Jan Scheffers
Selectivity and Activity of Benzene-1,2,4-triol and its Dimers as Antimicrobial Compounds Against Xanthomonas citri subsp. citri. ChemPlusChem 89 (6) (2024)
Christian S Carnero Canales, Aline Renata Pavan, Jean Leandro Dos Santos, Fernando Rogério Pavan
In silico drug design strategies for discovering novel tuberculosis therapeutics. Expert opinion on drug discovery 19 (4) (2024)
Lúcia B Cavalca, Úlfur Á Atlason, Alexandru Trofin, Camila M Ribeiro, Fernando Rogério Pavan, Peter Joseph Deuss, Dirk-Jan Scheffers
Selectivity and Activity of Benzene-1,2,4-triol and its Dimers as Antimicrobial Compounds Against Xanthomonas citri subsp. citri. ChemPlusChem (2024)
Christian S Carnero Canales, Aline Renata Pavan, Jean Leandro Dos Santos, Fernando Rogério Pavan
In silico drug design strategies for discovering novel tuberculosis therapeutics. Expert opinion on drug discovery 19 (4) (2024)
Ana P B Silva, Cesar Augusto Roque-Borda, Christian S Carnero Canales, Laura Maria Duran Gleriani Primo, Isabel Cristiane da Silva, Camila M Ribeiro, Marlus Chorilli, Patrícia Bento da Silva, Joás L Silva, Fernando Rogério Pavan
Activity of Bacteriophage D29 Loaded on Nanoliposomes against Macrophages Infected with Mycobacterium tuberculosis . Diseases (Basel, Switzerland) 11 (4) (2023)
Sílvio André Lopes, Cesar Augusto Roque-Borda, Jonatas Lobado Duarte, Leonardo Delello Di Filippo, Vinícius Martinho Borges Cardoso, Fernando Rogério Pavan, Marlus Chorilli, Andréia Bagliotti Meneguin
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease-An Overview. Pharmaceutics 15 (11) (2023)
Raphael Tristão Cruvinel Silva, Micaela Guidotti-Takeuchi, Jéssica Laura Miranda Peixoto, Fernanda Manaia Demarqui, Ananda Paula Mori, Carolyne Ferreira Dumont, Gabriella Rayane Aparecida Ferreira, Gabriele de Menezes Pereira, Daise Aparecida Rossi, Pedro Paulo Corbi, Fernando Rogério Pavan, Celso de Oliveira Rezende Junior, Roberta Torres de Melo, Wendell Guerra
New Palladium(II) Complexes Containing Methyl Gallate and Octyl Gallate: Effect against Mycobacterium tuberculosis and Campylobacter jejuni . Molecules (Basel, Switzerland) 28 (9) (2023)
Christian S Carnero Canales, Jessica Marquez Cazorla, André Henrique Furtado Torres, Eloise T M Filardi, Leonardo Delello Di Filippo, Paulo Inácio Costa, Cesar Augusto Roque-Borda, Fernando Rogério Pavan
Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection. Pharmaceutics 15 (10) (2023)
Raphael Tristão Cruvinel Silva, Micaela Guidotti-Takeuchi, Jéssica Laura Miranda Peixoto, Fernanda Manaia Demarqui, Ananda Paula Mori, Carolyne Ferreira Dumont, Gabriella Rayane Aparecida Ferreira, Gabriele de Menezes Pereira, Daise Aparecida Rossi, Pedro Paulo Corbi, Fernando Rogério Pavan, Celso de Oliveira Rezende Junior, Roberta Torres de Melo, Wendell Guerra
New Palladium(II) Complexes Containing Methyl Gallate and Octyl Gallate: Effect against Mycobacterium tuberculosis and Campylobacter jejuni . Molecules (Basel, Switzerland) 28 (9) (2023)
Cesar Augusto Roque-Borda, Fernando Rogério Pavan, Andréía Bagliotti Meneguin
Pharmaceutical Biotechnology. Life (Basel, Switzerland) 12 (8) (2022)
Camila M Ribeiro, Júlia A Grecco, Débora L Bellato, Aryadne L Almeida, Vanessa P Baldin, Katiany Rizzieri Caleffi Ferracioli, Fernando Rogério Pavan
Rescue of susceptibility to second-line drugs in resistant clinical isolates of Mycobacterium tuberculosis . Future microbiology 17 (2022)
Débora Leite Campos, Fernanda Manaia Demarqui, Mariana Cristina Solcia, Paula Carolina de Souza, Pedro Ivo da Silva Maia, Victor Marcelo Deflon, Fernando Rogério Pavan
Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria. Biomedicines 10 (10) (2022)
Karen Cristina Dos Santos, Camila Fernanda Rodero, Camila Maríngolo Ribeiro, Maria P D Gremião, Rosângela Gonçalves Peccinini, Fernando Rogério Pavan, Camron Pearce, Mercedes Gonzalez-Juarrero, Marlus Chorilli
Development of a Mucoadhesive Liquid Crystal System for the Administration of Rifampicin Applicable in Tuberculosis Therapy. Life (Basel, Switzerland) 12 (8) (2022)
Marina Paiva Abuçafy, Regina Celia Galvao Frem, Giulia Polinario, Fernando Rogério Pavan, Heng Zhao, Angelika Mielcarek, Cedric Boissiere, Christian Serre, Leila Aparecida Chiavacci
MIL-100(Fe) Sub-Micrometric Capsules as a Dual Drug Delivery System. International journal of molecular sciences 23 (14) (2022)
Guilherme da Costa de Souza, Cesar Augusto Roque-Borda, Fernando Rogério Pavan
Beta-lactam resistance and the effectiveness of antimicrobial peptides against KPC-producing bacteria. Drug development research 83 (7) (2022)
Cauê Benito Scarim, Fernando Rogério Pavan
Recent advancement in drug development of nitro(NO 2 )-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis. Drug development research 83 (4) (2022)
Nayla de Souza Pitangui, Junya de Lacorte Singulani, Janaina de Cássia Orlandi Sardi, Paula Carolina de Souza, Gabriela Rodríguez-Arellanes, Blanca Estela García-Pérez, Francisco Javier Enguita, Fernando Rogério Pavan, Maria Lucia Taylor, Maria José Soares Mendes-Giannini, Ana Marisa Fusco-Almeida
Differential miRNA Expression in Human Macrophage-Like Cells Infected with Histoplasma capsulatum Yeasts Cultured in Planktonic and Biofilm Forms. Journal of fungi (Basel, Switzerland) 7 (1) (2021)
Debora L Campos, Ignacio Machado, Camila M Ribeiro, Dinorah Gambino, Fernando Rogério Pavan
Bactericidal effect of pyridine-2-thiol 1-oxide sodium salt and its complex with iron against resistant clinical isolates of Mycobacterium tuberculosis. The Journal of antibiotics 73 (2) (2019)
Cristina P Matos, Yasemin Yildizhan, Zelal Adiguzel, Fernando Rogério Pavan, Débora L Campos, João Costa Pessoa, Liliana P Ferreira, Ana Isabel Tomaz, Isabel Correia, Ceyda Acilan
New ternary iron(iii) aminobisphenolate hydroxyquinoline complexes as potential therapeutic agents. Dalton transactions (Cambridge, England : 2003) 48 (24) (2019)
Carlos Roberto Polaquini, Guilherme S Torrezan, Vanessa R Santos, Ana C Nazaré, Débora L Campos, Laíza A Almeida, Isabel Cristiane da Silva, Henrique Ferreira, Fernando Rogério Pavan, Cristiane Duque, Luis O Regasini
Antibacterial and Antitubercular Activities of Cinnamylideneacetophenones. Molecules (Basel, Switzerland) 22 (10) (2017)

Fernando Rogério Pavan.css-eqlu8i{font-size:small;padding-left:4px;} (Fernando R Pavan, Fernando Rogerio Pavan)

Publication Activity (10 Years)

Top Topics

Top Venues

Fernando Rogério Pavan (Fernando R Pavan, Fernando Rogerio Pavan)